92 related articles for article (PubMed ID: 19622233)
1. Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts.
Bae JY; Kanamune J; Han DW; Matsumura K; Hyon SH
Cell Transplant; 2009; 18(4):459-69. PubMed ID: 19622233
[TBL] [Abstract][Full Text] [Related]
2. Nonfrozen preservation of articular cartilage by epigallocatechin-3-gallate reversibly regulating cell cycle and NF-kappaB expression.
Bae JY; Han DW; Matsumura K; Wakitani S; Nawata M; Hyon SH
Tissue Eng Part A; 2010 Feb; 16(2):595-603. PubMed ID: 19737073
[TBL] [Abstract][Full Text] [Related]
3. Hibernation, reversible cell growth inhibition by epigallocatechin-3-O-gallate.
Matsumura K; Kim JY; Tsutsumi S; Hyon SH
J Biotechnol; 2007 Jan; 127(4):758-64. PubMed ID: 16996160
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.
Han DW; Lee MH; Kim HH; Hyon SH; Park JC
Acta Pharmacol Sin; 2011 May; 32(5):637-46. PubMed ID: 21516136
[TBL] [Abstract][Full Text] [Related]
5. Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application.
Han DW; Jung DY; Park JC; Cho HH; Hyon SH; Han DK
J Biomed Mater Res A; 2010 Nov; 95(2):424-33. PubMed ID: 20648542
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
Jiao ZQ; Lü XZ; Guo YC; Kan B; Xu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):380-6. PubMed ID: 18206010
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids.
McLoughlin P; Roengvoraphoj M; Gissel C; Hescheler J; Certa U; Sachinidis A
Genes Cells; 2004 Jul; 9(7):661-9. PubMed ID: 15265009
[TBL] [Abstract][Full Text] [Related]
8. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
[TBL] [Abstract][Full Text] [Related]
9. Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.
Qiao Y; Cao J; Xie L; Shi X
Arch Pharm Res; 2009 Sep; 32(9):1309-15. PubMed ID: 19784588
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells.
Han DW; Matsumura K; Kim B; Hyon SH
Bioorg Med Chem; 2008 Nov; 16(22):9652-9. PubMed ID: 18951028
[TBL] [Abstract][Full Text] [Related]
11. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the biological activities of methylated derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) and their cell surface binding activities.
Yano S; Fujimura Y; Umeda D; Miyase T; Yamada K; Tachibana H
J Agric Food Chem; 2007 Aug; 55(17):7144-8. PubMed ID: 17661493
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
Lin SK; Chang HH; Chen YJ; Wang CC; Galson DL; Hong CY; Kok SH
Arthritis Rheum; 2008 Oct; 58(10):3145-56. PubMed ID: 18821707
[TBL] [Abstract][Full Text] [Related]
14. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
15. Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells.
Umeda D; Yano S; Yamada K; Tachibana H
Biochem Biophys Res Commun; 2008 Jun; 371(1):172-6. PubMed ID: 18423375
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of epigallocatechin-3-gallate on hypoxia injury to human umbilical vein, RF/6A, and ECV304 cells induced by Na(2)S(2)O(4).
Yu HN; Ma XL; Yang JG; Shi CC; Shen SR; He GQ
Endothelium; 2007; 14(4-5):227-31. PubMed ID: 17922339
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of epigallocatechin-3-O-gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts.
Han DW; Lee MH; Kim B; Lee JJ; Hyon SH; Park JC
Oxid Med Cell Longev; 2012; 2012():850684. PubMed ID: 23259030
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor activities of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo.
Matsumura K; Kaihatsu K; Mori S; Cho HH; Kato N; Hyon SH
Biochem Biophys Res Commun; 2008 Dec; 377(4):1118-22. PubMed ID: 18983978
[TBL] [Abstract][Full Text] [Related]
19. Involvement of microRNAs in epigallocatechin gallate-mediated UVB protection in human dermal fibroblasts.
An IS; An S; Park S; Lee SN; Bae S
Oncol Rep; 2013 Jan; 29(1):253-9. PubMed ID: 23076424
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate enhances the expression of genes related to insulin sensitivity and adipocyte differentiation in 3T3-L1 adipocytes at an early stage of differentiation.
Sakurai N; Mochizuki K; Kameji H; Shimada M; Goda T
Nutrition; 2009 Oct; 25(10):1047-56. PubMed ID: 19535224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
